Executive Overview
Nearly two years after its grand debut at the United Nations biodiversity summit in Cali, Colombia, a groundbreaking global financial instrument designed to bridge the gap between commercial biotechnology and planetary conservation is facing a stark reality check. The Cali Fund—conceived as a revolutionary mechanism to make major corporations pay for profiting from "digital sequence information" (DSI)—has brought in a mere trickle of revenue against its towering ambitions of mobilizing $1 billion annually.
Established to address a historic loophole where pharmaceutical, cosmetics, agricultural, and tech giants download and commercialize the genetic blueprints of the natural world without compensating its host nations or Indigenous guardians, the fund currently sits drastically under-capitalized. As preparatory meetings wrap up in Nairobi, Kenya, ahead of the upcoming COP17 biodiversity summit in Yerevan, Armenia, international officials, Indigenous representatives, and corporate sustainability experts are grappling with a multi-layered crisis of awareness, institutional architecture, and deep-seated corporate hesitation.
While small pioneers have stepped forward to break the ice, major multinational conglomerates remain on the sidelines, paralyzed by legal ambiguity, a lack of national recognition for compliance certificates, and corporate governance concerns. Yet, beyond the immediate shortfall in cash lies a profound philosophical test: whether the Cali Fund can evolve into a mechanism that does more than merely transfer funds—shifting the balance of power to ensure that Indigenous peoples and local communities hold the sovereign authority to dictate how global biodiversity benefits are shared.
Detailed Chronology: From Cali to Nairobi and the Road to Armenia
To understand the current stagnation of the Cali Fund, one must trace its origins through the crucible of international climate and biodiversity diplomacy.
- November 2024: Following grueling negotiations at the U.N. biodiversity summit (COP16) in Cali, Colombia, nations reach a historic consensus establishing the framework for digital sequence information benefit-sharing. Under Decision 16/2, companies exceeding specific financial thresholds—defined as having at least $20 million in assets, $50 million in sales, or $5 million in profit—are urged to contribute an indicative rate of 0.1% of revenue or 1% of profit to a newly minted U.N. trust account.
- February 25, 2025: The Cali Fund formally opens its doors for contributions, inviting voluntary corporate participation while setting the stage for institutional structuring.
- June 2025: In a parallel development showcasing alternative models, Malawi’s environmental authorities, national parks department, and university partner with U.K.-based AI and biotech firm Basecamp Research. Rather than focusing solely on monetary payouts, the landmark agreement prioritizes technology transfer, scientific training, and collaborative local research.
- July 2025: U.K.-based biotech firm Prozomix steps up to contribute $5,000 to the Cali Fund, demonstrating that smaller enterprises are willing to participate even when exempt from mandatory structures due to their size.
- November 19, 2025: A small U.K. artificial intelligence startup, TierraViva AI, officially transfers $1,000 to the U.N. trust account. Hailed by its chief executive as an "ice-breaker," the payment marks the very first cash received by the mechanism.
- July – August 2026: Negotiators and scientific advisors gather in Nairobi, Kenya, at the U.N. Environment Programme (UNEP) headquarters for preparatory workshops ahead of the COP17 summit. High-level discussions expose deep institutional growing pains, including a lack of dedicated staff, absent operational manuals, and glaring ambiguities surrounding certification recognition.
- October 19, 2026 (Upcoming): The Convention on Biological Diversity (CBD) COP17 summit is scheduled to open in Yerevan, Armenia, where governments face mounting pressure to resolve the structural roadblocks stalling the fund’s capitalization.
Supporting Context & Metrics: The Mechanics of the DSI Loophole
At the heart of the Cali Fund’s mission is a deeply entrenched technological shift that caught international environmental law flat-footed. For decades, traditional bioprospecting involved physical extraction—researchers collecting physical samples of plants, insects, or microbes from rainforests, coral reefs, and savannas. These activities were historically governed by complex bilateral access and benefit-sharing (ABS) rules.
However, the modern biotechnology landscape has digitized nature. Today, scientists can extract genetic material, sequence its DNA or RNA, and upload that digital sequence information (DSI) into open-access global databases. Once digitized, these genetic blueprints can be downloaded anywhere in the world by pharmaceutical, agricultural, cosmetics, and AI-driven drug-discovery firms. They can synthesize compounds, engineer proteins, and develop multi-billion-dollar therapeutic treatments or commercial crops without ever needing to physically return to the source country—effectively bypassing traditional benefit-sharing mechanisms.
Decision 16/2 was designed to close this loophole. It established that companies meeting specified asset, sales, or profit thresholds should contribute a modest percentage of their economic gains back to the global community. The structural promise of the fund is equally revolutionary: at least 50% of the mobilized resources are earmarked directly for Indigenous peoples and local communities, recognizing them as the primary stewards of the world’s remaining biodiversity hotspots. Furthermore, the framework allows for direct payments channeled through institutions chosen by the communities themselves, breaking away from historical models where funds were entirely funneled through centralized state governments.
Despite these grand aspirations, the numbers tell a sobering story. As of August 2026, the fund had recorded a total of just $6,000 across its confirmed contributions—a microscopic fraction of the $1 billion annual target.
| Metric / Milestone | Target / Design Specification | Current Reality (As of Mid-2026) |
|---|---|---|
| Annual Resource Mobilization | $1 Billion | ~$6,000 total confirmed contributions |
| Primary Contributors Targeted | Large corporations ($20M+ assets, $50M+ sales, $5M+ profit) | Small startups (e.g., TierraViva AI, Prozomix) |
| Community Allocation | At least 50% dedicated to Indigenous/Local communities | Limited by overall lack of capitalization |
| Institutional Framework | Fully operationalized manual, terms of reference, and review methodology | Still being drafted; interim operations run without dedicated staff |
Official Statements and Perspectives from the Frontlines
The chasm between policy design and operational reality has elicited sharp commentary from leaders across the conservation, indigenous, and corporate spheres.
The Secretariat’s View: Fighting Anonymity and the Novelty Challenge
Astrid Schomaker, executive secretary of the U.N. Convention on Biological Diversity (CBD), did not mince words during her interview at UNEP headquarters in Nairobi. She laid the blame squarely on a profound lack of global visibility and the innate corporate fear of being the first mover.
"Nobody knows about the fund," Schomaker told Mongabay. "There’s a really big novelty challenge, because it’s a fascinating new mechanism, but it’s a brand-new instrument, and hardly anybody heard about it."
Schomaker noted that the CBD Secretariat has been forced to manage the fund’s interim operations without dedicated staff. Addressing the reluctance of major corporations to step forward, she explained the boardrooms’ dilemma: "If you are the first contributor, you go to your shareholders and say, ‘There’s this new Cali Fund, I want to invest 20 million.’ And your shareholders say, ’20 million? Where’s the money going to go?’ I cannot say, because there are so many things that are open."
Despite this, Schomaker remains optimistic, predicting a "snowball effect" once large corporations finally break their silence, drawing parallels to other environmental financial instruments that experienced years of sluggish growth before taking off.
The Indigenous Voice: Seeking Agency, Not Just Charity
For Indigenous representatives embedded within the fund’s steering committees and global negotiations, the financial delay threatens to hollow out the transformative potential of the agreement.
Aleksei Tsykarev, an Indigenous peoples’ representative on the Cali Fund’s Steering Committee, emphasized that building trust must precede major capital inflows. "There is still a lack of information about the Cali Fund, the DSI, benefit sharing in general," Tsykarev said, noting that corporations require absolute clarity on how their contributions tangibly advance conservation conventions.
June Rubis, an Indigenous peoples’ representative from Asia, underscored that the much-touted 50% resource allocation to local communities is meaningless without actual capital. "The 50% commitment only becomes meaningful when there are sufficient resources to share," Rubis stated. However, she offered an important caveat regarding institutional development: "Institutional development cannot become a substitute for capitalization. We need both… If that happens, then the fund will be doing more than transferring finance. It will be helping to shift who gets to decide."
Legal Hurdles and Structural Critique
External legal analysts have pointed to foundational flaws that go beyond mere marketing. Nithin Ramakrishnan, a senior researcher at the Third World Network, highlighted a critical disconnect regarding corporate legal protections.
Companies contributing to the fund are promised a certificate demonstrating compliance with access and benefit-sharing laws. However, Ramakrishnan points out that almost no national government has enacted domestic legislation recognizing such certificates. "If countries and governments have not so far made a national legislation or a notification that they recognize the Cali Fund certificate, there is no guarantee to the company that putting money into the fund gives them this exemption," he warned. Furthermore, governments fear that recognizing the fund might be interpreted by their citizens as condoning the illegal export and extraction of national genetic data.
Ramakrishnan also raised alarms over administrative memorandums of understanding signed by U.N. partners that casually adopt the term "donor"—a label deliberately rejected by negotiators in Cali who insisted corporate contributions are benefit-sharing obligations, not acts of philanthropy. Left unamended, he warns, this language could grant powerful corporate legal teams undue oversight over audit records and fund expenditures.
The Corporate and Investor Perspective
Anita de Horde, executive director of the Finance for Biodiversity Foundation, offered a measured defense of the corporate sector, framing the current lull as a natural transition period. She noted that many large pharmaceutical and biotechnology firms genuinely support the Kunming-Montreal Global Biodiversity Framework’s 2030 nature-loss targets but are simply navigating a learning curve.
Her foundation is actively preparing investor guidance, launching around the time of the Armenia summit, to help investors pressure portfolio companies to engage with the mechanism. Nevertheless, de Horde cautioned that chronic under-funding risks undermining the broader narrative that private finance can successfully scale to protect global biodiversity.
Future Outlook: What Lies Ahead at COP17 in Armenia
As the conservation community turns its gaze toward the upcoming COP17 summit in Yerevan, Armenia, opening on October 19, 2026, the Cali Fund stands at a definitive crossroads.
Governments and negotiators will attempt to untangle a complex web of unresolved issues. High on the agenda will be refining indicative contribution rates, establishing ironclad allocation methodologies that satisfy corporate shareholder accountability, and carving out clearer rules for hybrid enterprises that utilize digital genetic data for only fractional segments of their business operations.
At the same time, developing nations in the Global South are increasingly exploring parallel bilateral agreements—such as Malawi’s pioneering partnerships focused on technology transfer and scientific training—demonstrating that nations will not passively wait for a centralized U.N. fund to deliver results. For some regions, contributions to the Cali Fund are already evolving into an unofficial prerequisite for securing market access, injecting coercive market dynamics into voluntary frameworks.
Ultimately, Schomaker’s challenge to the corporate world remains the defining ethos for the road to Yerevan: "It’s frankly not good enough for a company to say, ‘We have many questions,’ and [then] just sit there and wait. Maybe if you think it’s too new for you, make a gesture and start paying, and increase over time."
Whether the global corporate elite heeds that call will determine whether the Cali Fund becomes a historic milestone in planetary equity or remains a cautionary tale of a billion-dollar ambition lost in bureaucratic and legal limbo.
